Navigation Links
Clet Niyikiza, Merrimack's Executive Vice President of Development, to Present at BioVisionAlexandria 2010
Date:4/14/2010

Merrimack Pharmaceuticals, Inc. announced today that Clet Niyikiza, Ph.D., Executive Vice President of Development, will present at the BioVisionAlexandria 2010 conference as part of the panel, titled Cancer Care and Prevention: Novel Approaches.

Cambridge, MA (PRWEB) April 14, 2010 -- Clet Niyikiza, Ph.D., Executive Vice President of Development at Merrimack Pharmaceuticals, Inc., will present at the BioVisionAlexandria 2010 conference in Alexandria, Egypt.

The theme of this year’s fifth international biennial conference, put on by BioVision Alexandria, is New Life Sciences: Future Prospects. The goal of the conference is to get the greatest minds in industry, science, policy-making and civil society to identify and explore key areas in the field of life sciences that have the potential to serve a number of people across continents and cultures. Also featured in the conference is a Nobel Day where recipients of the Nobel Prize discuss the impact of their work and their future vision for the life sciences industry.

Dr. Niyikiza is speaking as part of a panel discussion in the Health portion of the conference which is built around the three major themes of Health, Food and Agriculture and Environment. The panel, titled Cancer Care and Prevention: Novel Approaches, takes place on Wednesday, April 14 from 3:30pm – 5:00pm.

About Merrimack
Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel medicines for the treatment of cancer and inflammation. The Company is advancing a robust pipeline of engineered therapeutics paired with molecular diagnostics. Merrimack’s first two oncology candidates, MM-121, partnered with sanofi-aventis, and MM-111, are in Phase 1 clinical testing with multiple pre-clinical development and research stage programs in the pipeline. MM-121 and MM-111 are investigational drugs and have not been approved by the U.S. Food and Drug Administration or any international regulatory agency. The Company’s proprietary Network Biology discovery platform, developed with the help of leading scientists from MIT and Harvard, integrates the fields of engineering, biology and computing to enable mechanism-based model driven discovery and development of both therapeutics and diagnostics. Merrimack is a privately-held company based in Cambridge, Massachusetts. For additional information, please visit http://www.merrimackpharma.com.

Contact: Kathleen Petrozzelli, Corporate Communications, 617-441-1043, Betsy Raymond Stevenson, 860-984-1424, RaymondStevenson Healthcare Comms

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3868554.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
2. Merrimack Pharmaceuticals Recognized for Innovative Talent Management in HR Executive Magazine's ‘Best HR Ideas for 2010' Issue
3. UPDATE: Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
4. Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
5. BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council
6. FMC Agricultural Products Executive Bob Trogele Speaks to the Iowa Agribusiness Showcase & Conference
7. Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board
8. Fibrocell Science, Inc. Names David Pernock Chief Executive Officer
9. Glycos Biotechnologies Appoints Chief Executive Officer
10. Biofuels Technology Leader Qteros Names Industry Veteran John McCarthy President and Chief Executive Officer
11. Marrone Bio Innovations Announces Two New Executive Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clet Niyikiza, Merrimack's Executive Vice President of Development, to Present at BioVisionAlexandria 2010
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee is ... honoring scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. ... world’s leading conference and exposition for laboratory science, which will be held February ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... At its ... Dr. Christopher Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has ... was a member of the winning team for the 2015 Breakthrough Prize in Fundamental ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... consulting for microscopy and surface analysis, Nanoscience Instruments is now expanding into ... a broad range of contract analysis services for advanced applications. Services will ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
Breaking Biology News(10 mins):